Brief: Emmaus Life Sciences Granted European Patent For Use Of Pharmaceutical-Grade L-Glutamine In Treating Diverticulosis
03/09/2019 13:34
Sept 3 (Reuters) - Emmaus Life Sciences Inc EMMA.O :
* EMMAUS LIFE SCIENCES GRANTED EUROPEAN PATENT FOR USE OF
PHARMACEUTICAL-GRADE L-GLUTAMINE IN TREATING DIVERTICULOSIS
Source text for Eikon: ID:nPn63Wdx8a
Further company coverage: EMMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns